Proprietary AI analyst is now available
- Public Comps
- Samsung C&T
Samsung C&T Valuation Multiples
Discover Samsung C&T's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Vingroup, Larsen & Toubro, Comfort Systems USA, Sun Hung Kai Properties and more.
Samsung C&T Overview
About Samsung C&T
Samsung C&T Corp is a diversified company. It is engaged in construction, trading, fashion, resort, food & beverages, and biopharmaceutical operations. The Construction division handles domestic and overseas construction projects, the Trading division engages in trading activities, and the Fashion division imports and sells apparel. The Resort division operates Everland, Caribbean Bay, and golf courses, while the Food and Beverages division manages specialty catering and food distribution through Samsung Welstory. The Bio division carries out biopharmaceutical contract manufacturing and biosimilar-related business.
Founded
1998
HQ

Employees
9.4K
Website
Financials (LTM)
EV
$56B
Valuation Multiples
Start free trialSamsung C&T Financials
Samsung C&T reported last 12-month revenue of $29B and EBITDA of $3B.
In the same LTM period, Samsung C&T generated $5B in gross profit, $3B in EBITDA, and $2B in net income.
Revenue (LTM)
Samsung C&T P&L
In the most recent fiscal year, Samsung C&T reported revenue of $29B and EBITDA of $4B.
Samsung C&T is profitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 12%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Samsung C&T Stock Performance
Samsung C&T has current market cap of $57B, and enterprise value of $56B.
Market Cap Evolution
Samsung C&T's stock price is $348.07.
Samsung C&T share price increased by 21.7% in the last 30 days, and by 221.0% in the last year.
Samsung C&T has an EPS (earnings per share) of $10.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $56B | $57B | 9.2% | 21.7% | 103.0% | 221.0% | $10.43 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSamsung C&T Valuation Multiples
Samsung C&T trades at 1.9x EV/Revenue multiple, and 18.4x EV/EBITDA.
EV / Revenue (LTM)
Samsung C&T Financial Valuation Multiples
As of June 5, 2026, Samsung C&T has market cap of $57B and EV of $56B.
Samsung C&T has a P/E ratio of 31.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Samsung C&T Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Samsung C&T Margins & Growth Rates
Samsung C&T grew revenue by 1% but EBITDA decreased by 13% in the last fiscal year.
In the most recent fiscal year, Samsung C&T reported gross margin of 18%, EBITDA margin of 12%, and net margin of 6%.
Samsung C&T Margins
Samsung C&T Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Samsung C&T Operational KPIs
Samsung C&T's revenue per employee in the last FY averaged $3.0M, while opex per employee averaged $0.3M for the same period.
Samsung C&T's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Samsung C&T's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Samsung C&T Competitors
Samsung C&T competitors include Vingroup, Larsen & Toubro, Comfort Systems USA, Sun Hung Kai Properties, Goodman Group, Hochtief, CRH, D.R. Horton, Grupo ACS and EMCOR Group.
Most Samsung C&T public comparables operate across Construction & Engineering and Real Estate Development.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.3x | 4.8x | 20.6x | 31.4x | |||
| 2.0x | 2.0x | 17.8x | 19.5x | |||
| 7.3x | 6.5x | 45.8x | 38.2x | |||
| 5.5x | 4.9x | 13.9x | 12.1x | |||
| 25.3x | 21.3x | 29.8x | 24.8x | |||
| 0.8x | 0.8x | 12.3x | 13.0x | |||
| 2.4x | 2.3x | 11.4x | 11.1x | |||
| 1.3x | 1.4x | 9.3x | 10.3x | |||
This data is available for Pro users. Sign up to see all Samsung C&T competitors and their valuation data. Start Free Trial | ||||||
Investments by Samsung C&T
Samsung C&T has invested in 6 companies to date.
Latest investment by Samsung C&T was on March 13th 2025. Samsung C&T invested in C2N Diagnostics in their $10M Strategic investment round (EV/Revenue multiple available to Pro users).
Latest Investments by Samsung C&T
| Description | C2N Diagnostics is a brain health laboratory developing blood-based biomarkers for Alzheimer's and neurodegeneration. Its PrecivityAD test detects amyloid plaques via plasma phospho-tau ratios for early diagnosis. St. Louis-headquartered, the firm supplies high-sensitivity assays to physicians and supports therapeutic discovery programs. | Robocon is a developer of robotics and automation equipment for construction and steel fabrication. The Singapore-based firm produces robotic welding systems, material handling robots, and assembly line automators deployed in factories across Asia. | CarbonCure Technologies is a green building innovator licensing CO2 injection systems that mineralize waste gas into concrete during production, permanently sequestering it while improving strength. Founded in 2007 and headquartered in Halifax, Nova Scotia, the retrofit technology serves over 1,000 ready-mix plants across the US and Canada. It provides marketing and certification support to help producers sell premium low-carbon concrete. | Neubility is a Seoul-based robotics company founded in 2017 that deploys self-driving delivery robots equipped with vision-based localization technology for urban parcel services. It conducts operations in high-density Asian cities handling frequent daily deliveries. | |
| HQ Country | |||||
| HQ City | Saint Louis, MO | Seongnam | Halifax | Seoul | |
| Deal Date | 13 Mar 2025 | 26 Sep 2023 | 11 Jul 2023 | 27 Apr 2022 | |
| Round | Strategic investment | Series A | Undisclosed stage | Series A | |
| Raised | $10M | $11M | $80M | $21M | |
| Investors | Samsung Bioepis; Samsung BioLogics; Samsung C&T; Samsung Venture Investment | Samsung C&T | 2150; BH3; Blue Earth Capital; Breakthrough Energy Ventures; Climate Pledge Fund; Microsoft Climate Innovation Fund; Samsung C&T; Samsung Ventures; Taronga Ventures | Capstone Partners; FuturePlay; IMM Investment; KB Investment; Lotte; Samsung C&T; Shinhan Capital; SHINSEGAE INFORMATION; Signite Partners | |
| Valuation | undisclosed | $34M | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Samsung C&T investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Samsung C&T
| When was Samsung C&T founded? | Samsung C&T was founded in 1998. |
| Where is Samsung C&T headquartered? | Samsung C&T is headquartered in South Korea. |
| How many employees does Samsung C&T have? | As of today, Samsung C&T has over 9K employees. |
| Is Samsung C&T publicly listed? | Yes, Samsung C&T is a public company listed on Korea Exchange. |
| What is the stock symbol of Samsung C&T? | Samsung C&T trades under 028260 ticker. |
| When did Samsung C&T go public? | Samsung C&T went public in 2014. |
| Who are competitors of Samsung C&T? | Samsung C&T main competitors include Vingroup, Larsen & Toubro, Comfort Systems USA, Sun Hung Kai Properties, Goodman Group, Hochtief, CRH, D.R. Horton, Grupo ACS, EMCOR Group. |
| What is the current market cap of Samsung C&T? | Samsung C&T's current market cap is $57B. |
| What is the current revenue of Samsung C&T? | Samsung C&T's last 12 months revenue is $29B. |
| What is the current revenue growth of Samsung C&T? | Samsung C&T revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Samsung C&T? | Current revenue multiple of Samsung C&T is 1.9x. |
| What is the current EBITDA of Samsung C&T? | Samsung C&T's last 12 months EBITDA is $3B. |
| What is Samsung C&T's EBITDA margin? | Samsung C&T's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Samsung C&T? | Current EBITDA multiple of Samsung C&T is 18.4x. |
| What is the current FCF of Samsung C&T? | Samsung C&T's last 12 months FCF is $1B. |
| What is Samsung C&T's FCF margin? | Samsung C&T's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Samsung C&T? | Current FCF multiple of Samsung C&T is 39.1x. |
| How many companies Samsung C&T has acquired to date? | Samsung C&T hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Samsung C&T has invested to date? | As of June 2026, Samsung C&T has invested in 6 companies. |
| What was the last Samsung C&T investment? | On 13th March 2025 Samsung C&T invested in C2N Diagnostics, participating in a $10M Strategic investment round, alongside Samsung Bioepis, Samsung BioLogics, and Samsung Venture Investment. |
| In what companies Samsung C&T invested in? | Samsung C&T invested in NuScale Power, CarbonCure Technologies, Neubility, Robocon, C2N Diagnostics, and Soltect Solchemical. |
See public comps similar to Samsung C&T
Lists including Samsung C&T
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


